Artificial Intelligence for Aging Research in Cancer Drug Development | Aging-US



December 5, 2023

  • Share
  • Aging-US published this trending editorial on November 18, 2023, in Volume 15, Issue 22, entitled, “Artificial intelligence for aging research in cancer drug development" by Dorsa Shirini, Lawrence H. Schwartz, and Laurent Dercle from the Department of Radiology, Columbia University Medical Center, New York, NY. DOI - Corresponding authors - Laurent Dercle - Sign up for free Altmetric alerts about this article - Subscribe for free publication alerts from Aging - Keywords - aging, artificial intelligence, cancer research About Aging-US Launched in 2009, Aging-US publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging-US go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways. Please visit our website at​​ and connect with us: SoundCloud - Facebook - X - Instagram - YouTube - LinkedIn - Pinterest - Media Contact 18009220957 MEDIA@IMPACTJOURNALS.COM

    AutomationCancer ResearchDrug Discovery

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.